W
ASHINGTON — Francis Collins, the director of the National Institutes of Health, chaired a meeting at the White House on Monday that many research advocates viewed as a chance to oppose the $5.8 billion cut President Trump has proposed for the agency next year.
Yet the topic of possible reductions in federal research funding, by Collins’ account, did not come up.
Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!
SUBSCRIBE TODAYWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
